Wuhan Multi-Omics Translational Medicine Research Center Co., Ltd.

Wuhan Multi-Omics Translational Medicine Research Center was established in 2018, specializing in sequencing detection and personalized bioinformatics analysis services for genomics, transcriptomics, proteomics, epigenomics, metabolomics, and microbiomics. It is committed to advancing translational medicine research through multi-omics technology services. Wuhan Multi-Omics Translational Medicine Research Center has a technologically advanced multi-omics detection platform and comprehensive data analysis platform, as well as an experienced technical team of master's and doctoral degree holders. It refines its service process from experimental detection plans, sample extraction and quality control, library construction and library inspection, to data collection and in-depth interpretation. Adhering to a sincere, professional, and efficient service attitude, and drawing on both theoretical knowledge and practical technical experience in life science research, it provides customers with professional service consulting advice, helping them through omics detection research to provide reliable evidence for exploring disease molecular mechanisms and discovering and validating targets. Wuhan Multi-Omics Translational Medicine Research Center has gained recognition and trust from an increasing number of cooperative customers through the stability of data output quality, the accuracy of data analysis, and professional pre-sales and after-sales guidance.